Jacobi Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Jacobi Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,134	Closed	-$82K	–	1020
2018 Q2	$82K	Hold	5,134	–	–	0.02%	351
2018 Q1	$61K	Hold	5,134	–	–	0.02%	360
2017 Q4	$61K	Hold	5,134	–	–	0.02%	336
2017 Q3	$72K	Hold	5,134	–	–	0.02%	288
2017 Q2	$81K	Sell	5,134 -3,582	-41%	-$52K	0.03%	242
2017 Q1	$120K	Hold	8,716	–	–	0.06%	139
2016 Q4	$114K	Hold	8,716	–	–	0.07%	130
2016 Q3	$115K	Hold	8,716	–	–	0.05%	138
2016 Q2	$96K	Buy	+8,716	New	+$85.2K	0.05%	147

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jacobi Capital Management's IRWD Position: Q3 2018 in Review

Jacobi Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2018, closing a stake of 5,134 shares — an estimated $82K sold.

Jacobi Capital Management first reported a position in IRWD in Q2 2016 and held it in 9 quarters. The position peaked at $120K in Q1 2017. 151 funds tracked by Wall St. Rank hold IRWD as of Q3 2018.

Jacobi Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Jacobi Capital Management sold 5,134 Ironwood Pharmaceuticals shares in Q3 2018, an estimated $82K.
Jacobi Capital Management first reported a position in Ironwood Pharmaceuticals in Q2 2016 and held it in 9 quarters.
Jacobi Capital Management's Ironwood Pharmaceuticals position peaked at $120K in Q1 2017.
151 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2018.

Based on Jacobi Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.